NCT02709187View on ClinicalTrials.gov

DP-R208 Pharmacokinetic Study

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Healthy
Interventions
DRUG

DP-R208

Investigational product is prescribed to all of randomized subjects

DRUG

Candesartan cilexetil

Investigational product is prescribed to all of randomized subjects

DRUG

Rosuvastatin

Investigational product is prescribed to all of randomized subjects

Sponsors

Lead Sponsor

Alvogen Korea
All Listed Sponsors
lead

Alvogen Korea

INDUSTRY